Jonathan Kennedy
CIK 1451629 · President and CEO · last filed 2021-05-04
Jonathan Kennedy is a President and CEO who has filed 56 SEC Form 4 insider transactions across 3 companies since 2013. The most recent filing shows the insider was granted $10.6K of NTUS on May 4, 2021. Across all open-market trades the lifetime net is −$6.9M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $1.9M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$1.88M
3
56
-$6.89M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| NATUS MEDICAL INC (NTUS) Delisted | President and CEO | 191,810 | $32.96 | $6.32M | -$505.6K | 8 | 2021-05-04 |
| IRMD | Director | 19,759 | $95.08 | $1.88M | $0 | 9 | 2019-06-19 |
| NATUS MEDICAL INC (BABY) Delisted | President and CEO | 139,517 | — | — | -$6.38M | 16 | 2019-01-24 |
Recent Filings
56 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-05-04 | NATUS MEDICAL INC (NTUS) Delisted | Grant (A) | +489 | $10.6K | EDGAR |
| 2021-04-16 | NATUS MEDICAL INC (NTUS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-01-05 | NATUS MEDICAL INC (NTUS) Delisted | Mixed | +29,036 | $619.9K | EDGAR |
| 2020-11-03 | NATUS MEDICAL INC (NTUS) Delisted | Grant (A) | +686 | $10.6K | EDGAR |
| 2020-01-14 | NATUS MEDICAL INC (NTUS) Delisted | Grant (A) | +42,101 | $1.38M | EDGAR |
| 2020-01-06 | NATUS MEDICAL INC (NTUS) Delisted | Tax (F) | −22,259 | -$726.8K | EDGAR |
| 2019-12-09 | NATUS MEDICAL INC (NTUS) Delisted | Mixed | +916 | -$39.8K | EDGAR |
| 2019-11-06 | NATUS MEDICAL INC (NTUS) Delisted | Mixed | +1,324 | -$69.8K | EDGAR |
| 2019-06-19 | IRMD | Exer (M) | +10,085 | $0 | EDGAR |
| 2019-01-24 | NATUS MEDICAL INC (BABY) Delisted | Grant (A) | +40,572 | $1.37M | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.